Skip to main content
. 2021 Apr 5;29(4):419–426. doi: 10.4062/biomolther.2021.003

Fig. 4.

Fig. 4

Effects of evogliptin, leucine, and the combination of these two agents on hepatic steatosis in HFD-fed mice. After eight weeks of the administration of evogliptin, leucine, or their combination in HFD-fed mice, the degree of hepatic steatosis was assessed by examining hepatic lipid accumulation histologically (A) and biochemically (B). Data are expressed as the means ± SEM. #p<0.05 vs. normal control mice, *p<0.05 vs. HFD-fed control mice.